Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2002 3
2003 6
2004 5
2005 2
2006 7
2007 3
2008 4
2009 3
2010 1
2011 5
2012 4
2013 6
2014 3
2015 6
2016 3
2017 3
2018 6
2019 6
2020 5
2021 6
2022 5
2023 2
2024 5

Text availability

Article attribute

Article type

Publication date

Search Results

88 results

Results by year

Filters applied: . Clear all
Page 1
Vaccine Safety: Assessing the Prevalence and Severity of Adverse Events Following COVID-19 Vaccination amongst Healthcare Workers in Tertiary Health Facilities in Nigeria.
Azees AS, Fasiku MM, Isa A, Ezenwoko AZ, Ahmed A, Temitayo-Oboh AO, Utulu R, Adeniyi MA, Musa A, Alo C, Ibrahim UM, Imhonopi GB, Adesoye OO, Okeke IM, John GT, Ayinla AY. Azees AS, et al. Among authors: john gt. Niger Postgrad Med J. 2024 Jan 1;31(1):1-7. doi: 10.4103/npmj.npmj_227_23. Epub 2024 Feb 7. Niger Postgrad Med J. 2024. PMID: 38321791 Free article.
A phase 1 study of triple-targeted therapy with BRAF, MEK, and AKT inhibitors for patients with BRAF-mutated cancers.
Algazi AP, Moon J, Lao CD, Chmielowski B, Kendra KL, Lewis KD, Gonzalez R, Kim K, Godwin JE, Curti BD, Latkovic-Taber M, Lomeli SH, Gufford BT, Scumpia PO, Lo RS, Othus M, Ribas A. Algazi AP, et al. Among authors: godwin je. Cancer. 2024 May 15;130(10):1784-1796. doi: 10.1002/cncr.35200. Epub 2024 Jan 23. Cancer. 2024. PMID: 38261444 Clinical Trial.
Leveraging a natural murine meiotic drive to suppress invasive populations.
Gierus L, Birand A, Bunting MD, Godahewa GI, Piltz SG, Oh KP, Piaggio AJ, Threadgill DW, Godwin J, Edwards O, Cassey P, Ross JV, Prowse TAA, Thomas PQ. Gierus L, et al. Among authors: godwin j. Proc Natl Acad Sci U S A. 2022 Nov 15;119(46):e2213308119. doi: 10.1073/pnas.2213308119. Epub 2022 Nov 8. Proc Natl Acad Sci U S A. 2022. PMID: 36346842 Free PMC article.
Lisocabtagene maraleucel as second-line therapy in adults with relapsed or refractory large B-cell lymphoma who were not intended for haematopoietic stem cell transplantation (PILOT): an open-label, phase 2 study.
Sehgal A, Hoda D, Riedell PA, Ghosh N, Hamadani M, Hildebrandt GC, Godwin JE, Reagan PM, Wagner-Johnston N, Essell J, Nath R, Solomon SR, Champion R, Licitra E, Fanning S, Gupta N, Dubowy R, D'Andrea A, Wang L, Ogasawara K, Thorpe J, Gordon LI. Sehgal A, et al. Among authors: godwin je. Lancet Oncol. 2022 Aug;23(8):1066-1077. doi: 10.1016/S1470-2045(22)00339-4. Epub 2022 Jul 12. Lancet Oncol. 2022. PMID: 35839786 Clinical Trial.
88 results